- Home
- SNTI vs NNVC Comparison
SNTI vs NNVC Comparison
Compare SNTI & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- NNVC
- Stock Information
- Founded
- SNTI 2016
- NNVC 2005
- Country
- SNTI United States
- NNVC United States
- Employees
- SNTI N/A
- NNVC N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- SNTI Health Care
- NNVC Health Care
- Exchange
- SNTI Nasdaq
- NNVC Nasdaq
- Market Cap
- SNTI 19.1M
- NNVC 22.0M
- IPO Year
- SNTI N/A
- NNVC N/A
- Fundamental
- Price
- SNTI $4.67
- NNVC $1.19
- Analyst Decision
- SNTI Strong Buy
- NNVC Strong Buy
- Analyst Count
- SNTI 1
- NNVC 1
- Target Price
- SNTI $12.00
- NNVC $6.50
- AVG Volume (30 Days)
- SNTI 115.8K
- NNVC 622.6K
- Earning Date
- SNTI 11-14-2024
- NNVC 02-12-2025
- Dividend Yield
- SNTI N/A
- NNVC N/A
- EPS Growth
- SNTI N/A
- NNVC N/A
- EPS
- SNTI N/A
- NNVC N/A
- Revenue
- SNTI N/A
- NNVC N/A
- Revenue This Year
- SNTI $11.52
- NNVC N/A
- Revenue Next Year
- SNTI $78.57
- NNVC N/A
- P/E Ratio
- SNTI N/A
- NNVC N/A
- Revenue Growth
- SNTI N/A
- NNVC N/A
- 52 Week Low
- SNTI $1.52
- NNVC $1.01
- 52 Week High
- SNTI $16.94
- NNVC $3.59
- Technical
- Relative Strength Index (RSI)
- SNTI 56.65
- NNVC 33.37
- Support Level
- SNTI $3.72
- NNVC $1.42
- Resistance Level
- SNTI $4.93
- NNVC $1.65
- Average True Range (ATR)
- SNTI 0.46
- NNVC 0.11
- MACD
- SNTI 0.01
- NNVC -0.04
- Stochastic Oscillator
- SNTI 81.82
- NNVC 13.21
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.